Scully M, Cataland SR, Peyvandi F, et al. Results of the Randomized, Double-Blind, Placebo-Controlled, Phase 3 Hercules Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura. ASH 59th Annual Meeting & Exhibition, abstract LBA-1.
Veiligheid en immunogeniciteit van 1 versus 2 doses BNT162b2 bij kankerpatiënten
jun 2021 | Vaccinatie, Virale infecties